Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Accumulated Expenses (2018 - 2025)

Dna X (SONM) has disclosed Accumulated Expenses for 8 consecutive years, with $13.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Accumulated Expenses fell 41.06% year-over-year to $13.6 million, compared with a TTM value of $13.6 million through Sep 2025, down 41.06%, and an annual FY2024 reading of $20.9 million, up 69.85% over the prior year.
  • Accumulated Expenses was $13.6 million for Q3 2025 at Dna X, up from $12.2 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $23.1 million in Q3 2024 and bottomed at $364000.0 in Q2 2023.
  • Average Accumulated Expenses over 5 years is $10.1 million, with a median of $11.0 million recorded in 2021.
  • The sharpest move saw Accumulated Expenses tumbled 91.16% in 2021, then skyrocketed 4766.48% in 2024.
  • Year by year, Accumulated Expenses stood at $11.4 million in 2021, then fell by 5.82% to $10.7 million in 2022, then increased by 15.04% to $12.3 million in 2023, then surged by 69.85% to $20.9 million in 2024, then crashed by 34.75% to $13.6 million in 2025.
  • Business Quant data shows Accumulated Expenses for SONM at $13.6 million in Q3 2025, $12.2 million in Q2 2025, and $15.1 million in Q1 2025.